Zeke Capital Advisors LLC lifted its position in shares of Intuitive Surgical (NASDAQ:ISRG) by 207.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,208 shares of the medical equipment provider’s stock after purchasing an additional 1,491 shares during the period. Zeke Capital Advisors LLC’s holdings in Intuitive Surgical were worth $806,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in the company. LPL Financial LLC grew its holdings in shares of Intuitive Surgical by 309.0% during the fourth quarter. LPL Financial LLC now owns 16,124 shares of the medical equipment provider’s stock worth $5,884,000 after purchasing an additional 12,182 shares during the last quarter. Flinton Capital Management LLC boosted its holdings in Intuitive Surgical by 183.9% in the fourth quarter. Flinton Capital Management LLC now owns 69,720 shares of the medical equipment provider’s stock valued at $25,443,000 after acquiring an additional 45,164 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its holdings in Intuitive Surgical by 298.7% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 7,329 shares of the medical equipment provider’s stock valued at $2,679,000 after acquiring an additional 5,491 shares during the last quarter. Cornerstone Capital Management Holdings LLC. boosted its holdings in Intuitive Surgical by 565.4% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 43,771 shares of the medical equipment provider’s stock valued at $15,972,000 after acquiring an additional 37,193 shares during the last quarter. Finally, OLD Mission Capital LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $711,000. Institutional investors own 87.85% of the company’s stock.
Several brokerages recently commented on ISRG. Vetr cut Intuitive Surgical from a “strong-buy” rating to a “buy” rating and set a $455.31 target price on the stock. in a report on Monday, April 2nd. Zacks Investment Research cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, March 27th. ValuEngine cut Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 21st. Finally, Citigroup cut their price target on Intuitive Surgical to $507.00 and set a “buy” rating on the stock in a report on Tuesday, February 6th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $413.84.
NASDAQ ISRG traded down $9.57 on Friday, reaching $396.55. The company had a trading volume of 627,621 shares, compared to its average volume of 753,755. The firm has a market capitalization of $44,834.73, a P/E ratio of 55.15, a PEG ratio of 4.72 and a beta of 0.57. Intuitive Surgical has a 52-week low of $251.13 and a 52-week high of $452.00.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.27. The business had revenue of $892.40 million during the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. Intuitive Surgical’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.03 EPS. research analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current fiscal year.
In other Intuitive Surgical news, SVP Mark J. Meltzer sold 24,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $433.00, for a total value of $10,392,000.00. Following the completion of the transaction, the senior vice president now owns 34,052 shares in the company, valued at approximately $14,744,516. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Salvatore Brogna sold 7,934 shares of the company’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $421.37, for a total value of $3,343,149.58. Following the completion of the transaction, the chief operating officer now owns 6,159 shares of the company’s stock, valued at approximately $2,595,217.83. The disclosure for this sale can be found here. Insiders sold a total of 102,770 shares of company stock valued at $43,410,836 over the last three months. 2.20% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/04/09/zeke-capital-advisors-llc-acquires-1491-shares-of-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.